Sunil Healthcare Limited

BSE: SUNLOC537253ISIN INE671C01016

Healthcare
Pharmaceuticals

Share price

₹66.84+3.81 (+6.04%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹82.31
52W low: ₹56.35
Off 52W high: -18.79%
1M return: -0.24%
3M return: -7.67%
6M return: +5.66%
1Y return: -9.64%
20D avg volume: 328
50 DMA: ₹71.43
200 DMA: ₹67.73

Key ratios Consolidated

Market cap: ₹68.54 Cr
Current price: ₹66.84
52W high / low: ₹82.31 / ₹56.35
Face value: ₹10.00
P/E: 19.25
P/B: 1.01
EPS (TTM): ₹3.47
Book value / share: ₹66.27
ROE: —
ROCE: 8.50%
Operating margin: —
Net margin: —
Debt / equity: 0.80
Net debt: ₹55.72 Cr
Interest cover: 1.36
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 199.3 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24
Income statement
	18.99	19.72	21.84	23.52	22.64	21.20	20.46	20.26	21.50	—
	0.23	0.41	0.50	0.42	0.86	0.49	0.53	0.18	0.14	—
	19.21	20.13	22.34	23.94	23.50	21.69	21.00	20.43	21.64	—
	19.01	20.96	21.49	22.64	22.47	21.41	21.34	20.95	22.28	—
	9.43	5.83	8.63	8.64	9.43	9.85	9.97	9.47	9.21	—
	0.04	0.02	0.11	0.00	0.03	0.03	0.02	0.05	0.06	—
	3.17	3.12	3.25	3.32	3.20	3.09	2.95	2.85	2.90	—
	1.50	1.66	1.66	1.40	1.44	1.56	1.89	1.50	1.51	—
	1.46	1.52	1.62	1.64	1.66	1.68	1.69	1.51	1.49	—
	5.77	7.50	6.92	8.17	6.69	5.96	6.33	6.20	6.20	—
	0.20	-0.83	0.84	1.30	1.03	0.28	-0.34	-0.51	-0.65	—
	0.00	-0.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.20	-0.95	0.84	1.30	1.03	0.28	-0.34	-0.51	-0.65	—
	-0.26	2.46	0.26	0.31	0.12	-0.08	0.20	0.04	0.04	—
	0.46	1.52	0.59	1.00	0.91	0.36	-0.54	-0.55	-0.69	—
	0.45	1.48	0.57	0.97	0.89	0.35	-0.53	-0.53	-0.67	—
Key metrics
	3.16	2.23	4.12	4.34	4.13	3.52	3.24	2.50	2.35	—
	16.60%	11.30%	18.90%	18.50%	18.20%	16.60%	15.80%	12.30%	10.90%	—
	2.40%	7.70%	2.70%	4.30%	4.00%	1.70%	-2.60%	-2.70%	-3.20%	—
	—	0.70%	—	2.80%	—	1.90%	—	—	—	—
	-16.10%	-7.00%	6.70%	16.10%	5.30%	—	—	—	—	—
	-49.50%	322.20%	209.30%	281.80%	231.90%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	84.07	87.72	83.42	—
	1.56	2.18	1.34	—
	85.62	89.90	84.76	—
	84.10	87.56	85.98	—
	32.53	32.52	38.50	—
	0.17	0.15	0.16	—
	12.86	12.89	11.80	—
	6.22	6.16	6.46	—
	6.24	6.44	6.36	—
	28.36	29.28	24.70	—
	1.51	2.35	-1.22	—
	-0.12	-0.12	0.00	—
	1.39	2.23	-1.22	—
	2.77	-1.78	0.20	—
	3.57	4.01	-1.42	—
	3.47	3.91	-1.38	—
Key metrics
	13.85	14.83	11.60	—
	16.47%	16.90%	13.90%	—
	4.25%	4.60%	-1.70%	—
	—	8.50%	5.30%	—
	-0.58%	5.20%	—	—
	1,883.33%	382.40%	—	—
	—	18.56	2.09	—
	—	5.52	-8.11	—
	—	0.80	1.02	—
	—	55.72	68.61	—
	—	199.3	220.4	—
Balance sheet
	—	164.51	161.94	—
	—	73.86	65.11	—
	—	0.07	0.03	—
	—	45.13	41.64	—
	—	18.74	17.64	—
	—	3.87	2.26	—
	—	85.83	94.04	—
	—	15.98	8.91	—
	—	66.34	62.60	—
	—	55.79	68.64	—
	—	40.28	49.24	—
	—	15.51	19.40	—
	—	69.60	67.07	—
Cash flow
	—	22.15	11.52	—
	—	-2.85	-7.70	—
	—	-19.26	-3.87	—
	—	3.59	9.43	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24
Income statement
	18.99	19.72	21.84	23.52	22.64	21.20	20.46	20.26	21.50	—
	0.23	0.35	0.35	0.21	0.23	0.50	0.55	0.19	0.10	—
	19.21	20.07	22.19	23.73	22.88	21.71	21.02	20.45	21.60	—
	18.97	19.77	21.49	22.63	22.47	21.53	20.91	20.38	21.54	—
	9.43	5.83	8.63	8.64	9.43	9.85	9.97	9.47	9.21	—
	0.04	0.02	0.11	0.00	0.03	0.03	0.02	0.05	0.06	—
	3.17	3.12	3.25	3.32	3.20	3.09	2.95	2.85	2.91	—
	1.50	1.66	1.66	1.40	1.44	1.56	1.89	1.50	1.51	—
	1.46	1.52	1.62	1.64	1.66	1.68	1.69	1.51	1.48	—
	5.73	7.50	6.91	8.17	6.69	6.08	5.90	5.65	5.46	—
	0.25	0.30	0.70	1.10	0.41	0.18	0.11	0.07	0.06	—
	0.00	-9.58	0.00	0.00	0.00	0.00	—	—	—	—
	0.25	-9.28	0.70	1.10	0.41	0.18	0.11	0.07	0.06	—
	-0.26	2.46	0.26	0.31	0.12	-0.08	0.20	0.04	0.04	—
	0.51	-6.82	0.44	0.79	0.29	0.25	-0.09	0.03	0.01	—
	0.50	6.65	0.43	0.77	0.28	0.25	-0.09	0.03	0.01	—
Key metrics
	3.21	-6.10	3.98	4.14	3.51	3.42	3.69	3.08	3.05	—
	16.90%	-30.90%	18.20%	17.60%	15.50%	16.10%	18.00%	15.20%	14.20%	—
	2.70%	-34.60%	2.00%	3.40%	1.30%	1.20%	-0.40%	0.10%	0.00%	—
	—	-7.90%	—	2.40%	—	1.60%	—	—	—	—
	-16.10%	-7.00%	6.70%	16.10%	5.30%	—	—	—	—	—
	75.90%	-2,828.00%	588.90%	2,533.30%	2,800.00%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	84.07	87.72	83.42	—
	1.14	1.14	1.35	—
	85.20	88.86	84.77	—
	82.86	86.36	84.37	—
	32.53	32.52	38.50	—
	0.17	0.15	0.16	—
	12.86	12.89	11.80	—
	6.22	6.16	6.46	—
	6.24	6.44	6.35	—
	28.31	29.27	23.09	—
	2.35	2.50	0.41	—
	-9.58	-9.58	0.00	—
	-7.23	-7.08	0.41	—
	2.77	-1.78	0.20	—
	-5.08	-5.30	0.21	—
	8.35	5.17	0.20	—
Key metrics
	5.23	5.52	13.22	—
	6.22%	6.30%	15.80%	—
	-6.04%	-6.00%	0.30%	—
	—	-1.00%	6.50%	—
	-0.58%	5.20%	—	—
	-1,158.33%	-2,623.80%	—	—
	—	18.56	2.11	—
	—	-4.18	54.95	—
	—	0.82	0.93	—
	—	55.72	68.62	—
	—	194.7	247.9	—
Balance sheet
	—	162.32	168.21	—
	—	71.69	71.39	—
	—	0.07	0.02	—
	—	43.69	48.50	—
	—	18.74	16.74	—
	—	3.15	1.69	—
	—	85.83	94.04	—
	—	15.65	8.58	—
	—	65.92	62.28	—
	—	55.79	68.64	—
	—	40.28	49.24	—
	—	15.51	19.40	—
	—	67.84	73.66	—
Cash flow
	—	22.15	11.54	—
	—	-2.85	-7.70	—
	—	-19.26	-3.87	—
	—	3.59	9.43	—

Compounded growth

Standalone

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): -0.58%
Profit YoY (TTM): -1,158.33%

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): -0.58%
Profit YoY (TTM): +1,883.33%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 73.53%

Holder	Type	Holding	Previous	Change
ANIL KUMAR KHAITAN	Promoter	57.95%	—	—
MAGNUM COMPUTERS PRIVATE LIMITED	Promoter	12.94%	—	—
SHAILESH KUMAR	Public	6.84%	—	—
SUNLOC FOODS PRIVATE LIMITED	Public	5.30%	—	—
RENU MODI	Promoter	2.64%	—	—
MAGADH TRADERS LTD	Public	1.54%	—	—
KANCHAN SUNIL SINGHANIA	Public	1.21%	—	—

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Sun Pharmaceutical Industries Ltd.	4,26,112	1,776.00	38.78	17.90%	+12.13% TTM	+4.79% TTM	+4.92%
Divi's Laboratories Ltd.	2,66,424	10,036.00	91.09	19.00%	+16.35% TTM	+26.84% TTM	+47.61%
Torrent Pharmaceuticals Ltd.	1,79,908	4,730.00	85.71	9.10%	+42.06% TTM	-1.92% TTM	+32.24%
Laurus Labs Limited	1,24,601	2,306.10	93.53	19.70%	+23.03% TTM	+95.38% TTM	+134.59%
Zydus Lifesciences Limited	1,18,703	1,190.00	25.85	19.20%	+21.11% TTM	-2.51% TTM	+22.32%
Dr. Reddy's Laboratories Ltd.	1,14,513	1,372.00	41.50	13.90%	-3.53% TTM	-51.90% TTM	+14.26%
Cipla Ltd.	1,13,110	1,400.10	39.63	14.90%	-0.74% TTM	-47.48% TTM	-6.88%
Mankind Pharma Limited	1,04,631	2,533.15	46.22	13.70%	+13.27% TTM	+27.60% TTM	+6.91%
Aurobindo Pharma Ltd.	97,878	1,701.10	26.38	13.60%	+9.09% TTM	+9.48% TTM	+47.79%
Lupin Ltd	92,145	2,015.00	17.65	28.40%	+24.22% TTM	+20.10% TTM	+0.84%
Glenmark Pharmaceuticals ltd	70,608	2,501.85	39.27	16.20%	+32.94% TTM	+138.48% TTM	+35.48%
Alkem Laboratories Limited	62,054	5,190.00	28.15	18.80%	+13.36% TTM	-5.52% TTM	-8.38%
Abbott India Ltd. S	57,685	27,146.85	35.73	41.90%	+6.29% TTM	+11.18% TTM	-7.56%
Biocon Ltd.	56,061	344.00	134.63	2.90%	+5.70% TTM	-55.37% TTM	-9.53%
Gland Pharma Limited	52,105	3,157.70	46.16	13.70%	+17.57% TTM	+46.55% TTM	+65.09%
Ipca Laboratories Ltd.	50,051	1,973.15	36.40	16.40%	+10.59% TTM	+67.91% TTM	+52.33%
GlaxoSmithkline Pharmaceuticals Ltd.	42,904	2,532.60	37.42	55.40%	+12.12% TTM	+20.03% TTM	-4.84%
Ajanta Pharma Ltd.	41,406	3,313.55	32.79	29.40%	+25.01% TTM	+29.70% TTM	+26.89%
Emcure Pharmaceuticals Limited	41,254	2,174.55	37.75	25.10%	+21.12% TTM	+33.34% TTM	+64.07%
J.B. Chemicals & Pharmaceuticals Lt	38,731	2,412.25	47.77	21.90%	+5.87% TTM	+7.56% TTM	+45.79%
Sai Life Sciences Limited	32,855	1,546.30	90.80	18.10%	—	—	+67.49%
PIRAMAL PHARMA LIMITED	31,659	237.80	-151.21	0.80%	+9.43% TTM	-781.93% TTM	+18.60%
ACUTAAS CHEMICALS LIMITED	30,928	3,777.65	70.51	27.70%	+45.18% TTM	+95.78% TTM	+106.30%
Wockhardt Ltd	30,869	1,899.80	76.22	6.40%	+25.70% TTM	+894.12% TTM	+39.18%
RUBICON RESEARCH LIMITED	28,416	1,716.55	98.59	24.30%	—	—	+164.06%
Sunil Healthcare Limited	69	66.84	19.25	8.50%	-0.58% TTM	+1,883.33% TTM	-9.64%

Filings & corporate actions

Recent announcements

Sunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Intimation of Board Meeting ....3 Nov 2026 · Board Meeting / Board Meeting
Compliance certificate for the quarter ended 30.09.2026 under regulation 74(5) of SEBI (DP) Regulations8 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Revision of Credit Ratings5 Oct 2026 · Company Update / Credit Rating
Voting Results and Scrutinizers Report dated 29.09.2026 of 52nd AGM of Sunil Healthcare Limited held on Monday, 28th September 2026 at 12.30 P.M.29 Sep 2026 · AGM/EGM / AGM
Proceedings of 52nd AGM of Sunil Healthcare Limited held on Monday, 28th September 2026 at 12.30 P.M.28 Sep 2026 · AGM/EGM / AGM
Trading window of the Company shall remain close from October 01, 2026 till 48 hours of the declaration of un-audited financial results for the 2nd quarter/half year of FY 2026-27 ending on 30.09.202625 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Book Closure period from 22nd September to 28th September 2026 for the purpose of 52nd AGM of the Company to be held on 28th September 2026 at 12.30 p.m. through VC/OAVM and Cut off date ....14 Sep 2026 · Corp. Action / Book Closure
Copy of newspaper publications about dispatch of 52nd AGM Notice and Annual Report 2025-26 to shareholders of Company including book closure intimation etc.3 Sep 2026 · Company Update / Newspaper Publication
Annual Report for the FY 2025-262 Sep 2026 · Others / Reg. 34 (1) Annual Report
Notice of 52nd Annual General Meeting of the Company,. Remote-E-voting/E-voting and other information2 Sep 2026 · AGM/EGM / AGM
Publication of notice in newspaper for updation of email id and enabling temporary facility for updation of email Id by shareholders with Evoting agency/ Video Conferencing agency for ensuing ....21 Aug 2026 · Company Update / Newspaper Publication
Copy of Newspaper publication of Un-audited financial results (both standalone and consolidated) for the quarter ended 30th June 202615 Aug 2026 · Company Update / Newspaper Publication
Outcome of Board meeting held on 13th August 202613 Aug 2026 · Board Meeting / Outcome of Board Meeting
approved un-audited financial results (both standalone and consolidated) for the 1st quarter of FY 2026-27 ended on 30.06.202613 Aug 2026 · Result / Financial Results
Sunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve Board Meeting scheduled to ....31 Jul 2026 · Board Meeting / Board Meeting
Compliance Certificate for the 1st quarter of FY 2026-27 ended 30th June 2026 under Reg. 74(5) of SEBI (DP) regulations6 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Special window for Transfer and Dematerialisation of Physical Securities30 Jun 2026 · Company Update / General
Trading Window Closure Notice for the declaration of Un-audited financial results of the Company for the 1st quarter of FY 2026-27 ended on 30.06.202626 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Copy of newspaper publication dated 31.05.2026 of the financial results for the quarter/year ended 31.03.20631 May 2026 · Company Update / Newspaper Publication
Annual Secretarial Compliance Report for the Financial year 2025-2630 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Approved Audited Financial Results (Standalone and Consolidated) for the quarter/year ended 31.03.202629 May 2026 · Result / Financial Results
Outcome of the 269th Board Meeting of the Company held on 29.05.202629 May 2026 · Board Meeting / Outcome of Board Meeting
Approved Audited Financial Results (Standalone and Consolidated) for the quarter/year ended March 31, 202629 May 2026 · Result / Financial Results
Sunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Meeting of the Board of Directors ....19 May 2026 · Board Meeting / Board Meeting
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''><tr> <td>Sr. No.</td> <td>Particulars</td> <td>Details</td> ....24 Apr 2026 · Others / Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Compliance Certificate under Regulation 40(10) of SBI LODR for the year ended 31st March 202616 Apr 2026 · Company Update / Reg. 40 (10) - PCS Certificate for Transfer / Transmission / Transposition
Compliance Certificate u/r 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 31st March 20267 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Intimation of Closure of Trading Window for the declaration of audited financial results for the 4th quarter/ financial year ended 31.03.202627 Mar 2026 · Insider Trading / SAST / Closure of Trading Window
Newspaper clippings regarding publication of un-audited financial results for 3rd quarter/9 months ended 31st December 2025 (both standalone and consolidated)8 Feb 2026 · Company Update / Newspaper Publication
Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, we are pleased to inform, that the Board of Directors of the Company at their Board Meeting held on Friday, February 06, ....6 Feb 2026 · Board Meeting / Outcome of Board Meeting
Board at its meeting held today interalia approved Unaudited Financial Results (both standalone and consolidated) for the quarter and nine months ended 31.12.2025 of FY 2025-266 Feb 2026 · Result / Financial Results
Sunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 ,inter alia, to consider and approve Intimation of Board Meeting ....28 Jan 2026 · Board Meeting / Board Meeting
Compliance certificate under Regulation 74(5) of SEBI (DP) regulations 2018 for quarter ended 31.12.20257 Jan 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Trading window of the Company shall remain close from January 01, 2026 till 48 hours after the declaration of the un-audited financial results for the 3rd quarter/nine months of financial ....29 Dec 2025 · Insider Trading / SAST / Closure of Trading Window
Copy of newspaper publication dated 06.11.2025 (both hindi and english) regarding un-audited financial results for the quarter/half year ended 30.09.20256 Nov 2025 · Company Update / Newspaper Publication
Board of Directors at its meeting held today on 04.11.2025 interalia approved un-audited financial results(both standalone and consolidated) for the quarter/half year ended 30.09.20254 Nov 2025 · Board Meeting / Outcome of Board Meeting
Board of Directors at its meeting held today on 04.11.2025 interalia approved Unaudited Financial results (both standalone and consolidated) for the quarter/half year ended 30.09.20254 Nov 2025 · Result / Financial Results
Sunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2025 ,inter alia, to consider and approve Board Meeting of the Company ....24 Oct 2025 · Board Meeting / Board Meeting
Compliance Certificate under Regulation 74(5) of of SEBI (DP) Regulations, 2018 for the 2nd quarter ended 30.09.20257 Oct 2025 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Approval of appointment of M/s. ATCS & Associates, Company Secretaries as Secretarial Auditors of the Company for a term of 5 consecutive years from the FY 2025-26 upto FY 2029-30 by the ....30 Sep 2025 · Company Update / General

Board meetings

13 Nov 2026 Board Meeting - Financial Results
13 Aug 2026 Board Meeting - Financial Results